Can an AI coach help cancer survivors feel better? new trial tests emotional training app

NCT ID NCT07611071

Not yet recruiting Symptom relief Sponsor: The Hong Kong Polytechnic University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a 4-week AI chatbot program called AI-EGG that teaches emotional skills to young and middle-aged colorectal cancer survivors. The goal is to see if it helps them build resilience and improve quality of life. Fifty-four participants will be randomly assigned to either the chatbot program or standard care, and researchers will measure changes in emotional awareness and well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI chatbot-based emotional training program
What this could lead to: If it works, this could offer a new way to help cancer survivors manage emotions and build resilience after treatment.
What could go wrong: This is a small early-stage trial with only 54 participants, so results may not apply to everyone. The program is digital and requires active engagement, which may not suit all survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (CRC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm Emotional Regulation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL CANCER (CRC)

Contacts and locations

Locations

Kunshan First People's Hospital Affiliated to Jiangsu University

Kunshan, Jiangsu, 215300, China
The First Affiliated Hospital of Soochow University

Suzhu, Jiangsu, 215000, China
The Second Affiliated Hospital of Soochow University

Suzhou, Jiangsu, 215000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.